Treatment . | ATT . | ATT . | ATT . | ATT . |
---|---|---|---|---|
(at least one EP) . | (at least 5 EPs) . | (at least one IEA) . | (at least five IEAs) . | |
EPs (at least one) | 35.32*** (9.71) | |||
EPs (at least five) | 48.24*** (10.73) | |||
IEAs (at least one) | 10.53 (10.91) | |||
IEAs (at least five) | −3.28 (10.09) | |||
Observations | 2,792 | 2,792 | 2,792 | 2,792 |
R-squared (goodness of fit in probit model/selection stage) | 0.1105 | 0.1173 | 0.0498 | 0.0404 |
Mean bias after matching (%) | 4.7 | 4.4 | 7.5 | 3.2 |
Treatment . | ATT . | ATT . | ATT . | ATT . |
---|---|---|---|---|
(at least one EP) . | (at least 5 EPs) . | (at least one IEA) . | (at least five IEAs) . | |
EPs (at least one) | 35.32*** (9.71) | |||
EPs (at least five) | 48.24*** (10.73) | |||
IEAs (at least one) | 10.53 (10.91) | |||
IEAs (at least five) | −3.28 (10.09) | |||
Observations | 2,792 | 2,792 | 2,792 | 2,792 |
R-squared (goodness of fit in probit model/selection stage) | 0.1105 | 0.1173 | 0.0498 | 0.0404 |
Mean bias after matching (%) | 4.7 | 4.4 | 7.5 | 3.2 |